openPR Logo
Press release

Plasma Protein Therapeutics Market to Reach USD 58.30 Billion by 2035

12-29-2025 10:53 AM CET | Health & Medicine

Press release from: Expert Market Research

Plasma Protein Therapeutics Market to Reach USD 58.30 Billion

Is the Plasma Protein Therapeutics Market Poised for Transformative Growth in Healthcare?

Plasma Protein Therapeutics Market: Global Analysis, Trends, and Forecast

The Plasma Protein Therapeutics Market is a crucial segment within the global biopharmaceutical industry, driven by the increasing prevalence of chronic and rare diseases, growing awareness of plasma-derived therapies, and expanding healthcare infrastructure worldwide. Plasma protein therapeutics are vital in managing conditions such as hemophilia, primary immunodeficiencies, and idiopathic thrombocytopenic purpura (ITP), providing life-saving interventions to patients globally.

In 2025, the global market was valued at USD 32.25 billion. With rising adoption of plasma-derived therapies and advances in biopharmaceutical production, the market is projected to grow at a CAGR of 6.10% during 2026-2035, reaching USD 58.30 billion by 2035.

Get a Free Sample Report with Table of Contents - https://www.expertmarketresearch.com/reports/plasma-protein-therapeutics-market/requestsample.

Understanding Plasma Protein Therapeutics

Plasma protein therapeutics are derived from human plasma and are used to treat a range of immune deficiencies, bleeding disorders, and other medical conditions. Common plasma proteins include:

Immunoglobulin (IVIG/SCIG): Used in immune deficiency treatment

Albumin: Maintains blood volume and pressure in critically ill patients

Plasma-derived clotting factors: Essential for hemophilia management

These therapies have proven clinical efficacy and are increasingly integrated into standard care protocols, driving sustained demand.

Market Overview and Dynamics

The Plasma Protein Therapeutics Market is expanding due to multiple factors:

Rising prevalence of rare and chronic diseases such as hemophilia and primary immunodeficiencies.

Increased plasma collection initiatives in developed and emerging economies.

Technological advancements in plasma fractionation and purification processes.

Growing adoption in home care and ambulatory settings, enhancing patient convenience.

Regulatory support and favorable reimbursement policies in key markets.

Market Size and Growth Forecast

Market Value (2025): USD 32.25 Billion

Forecast Value (2035): USD 58.30 Billion

CAGR (2026-2035): 6.10%

This steady growth is indicative of increasing clinical reliance on plasma-derived therapeutics, as well as expanding patient populations globally.

Key Growth Drivers

Rising Incidence of Chronic and Rare Diseases

Conditions like hemophilia, ITP, and primary immunodeficiencies have driven a steady demand for plasma protein therapies. Early diagnosis and enhanced awareness of treatment options further fuel adoption.

Expanding Home Healthcare and Ambulatory Services

Plasma protein therapies are increasingly administered in home care settings, improving patient compliance, reducing hospital visits, and enabling cost-efficient treatment.

Technological Advancements in Manufacturing

Innovations in plasma fractionation, purification, and formulation increase safety, product stability, and treatment efficacy, enhancing market confidence.

Growing Plasma Donation Programs

Government and private initiatives to boost plasma donation contribute to a reliable supply chain, supporting sustainable market growth.

Aging Population

An older population with higher susceptibility to chronic diseases is increasing the need for plasma-derived therapeutics.

Emerging Trends in the Plasma Protein Therapeutics Market

Shift Towards Recombinant and Subcutaneous Formulations

Recombinant clotting factors and subcutaneous immunoglobulin therapies offer convenience, reduced side effects, and improved patient adherence.

Personalized and Targeted Therapeutics

Developments in personalized medicine are enabling tailored dosing and treatment protocols, improving outcomes.

Expansion in Emerging Economies

Increasing healthcare access and medical awareness in Asia Pacific, Latin America, and the Middle East is driving regional market growth.

Integration of Digital Health Solutions

Remote monitoring, telemedicine, and home infusion support are enhancing patient engagement and therapy adherence.

Strategic Collaborations and Partnerships

Collaborations between biopharmaceutical companies and plasma collection centers are strengthening supply chains and expanding product portfolios.

Read the Full Report with the Table of Contents - https://www.expertmarketresearch.com/reports/plasma-protein-therapeutics-market.

Market Segmentation Analysis

Market Breakup by Product Type

Immunoglobulin: Dominates the market, used for primary immunodeficiencies, autoimmune diseases, and ITP.

Albumin: Key in critical care for volume replacement and hypoalbuminemia.

Plasma-Derived Factors: Primarily for hemophilia and bleeding disorders.

Others: Include specialized proteins like antithrombin, alpha-1 antitrypsin, and coagulation factor concentrates.

Market Breakup by Applications

Hemophilia: Large patient base requiring regular infusion therapy.

Idiopathic Thrombocytopenic Purpura (ITP): Increased prevalence fuels demand.

Primary Immunodeficiencies: Chronic treatment needs drive consistent market demand.

Other Applications: Include secondary immunodeficiencies, sepsis, and critical care interventions.

Market Breakup by End User

Hospitals: Largest segment due to acute care and inpatient treatments.

Home Care: Rapidly growing segment driven by convenience and patient adherence.

Ambulatory Surgical Centers (ASCs): Expanding adoption for outpatient procedures.

Market Breakup by Region

North America

Dominates the market due to high plasma donation rates, advanced healthcare infrastructure, and strong reimbursement policies.

Europe

Stable growth supported by well-established plasma fractionation facilities and robust regulatory frameworks.

Asia Pacific

Fastest-growing region due to rising patient awareness, expanding healthcare access, and increasing plasma collection programs.

Latin America

Emerging demand driven by urbanization, rising disposable income, and improving healthcare infrastructure.

Middle East and Africa

Gradual growth supported by investment in healthcare infrastructure and increasing awareness of rare diseases.

Competitive Landscape

The plasma protein therapeutics market is moderately consolidated, with a combination of global biopharmaceutical giants and regional players competing on innovation, product portfolio, and geographic reach.

Key Companies Covered

CSL Limited

Baxter International

Bio Products Laboratory Ltd

Octapharma AG

Kedrion SpA

Becton, Dickinson and Company

Takeda Pharmaceutical

Grifols, S.A.

ADMA Biologics Inc

Bayer AG

Strategic initiatives include mergers and acquisitions, partnerships with plasma centers, and expansion into emerging markets.

Challenges in the Plasma Protein Therapeutics Market

Despite robust growth, the market faces several challenges:

Limited plasma availability: A constant challenge for global supply.

High production costs: Plasma fractionation is resource-intensive.

Regulatory complexities: Varying standards across countries complicate market entry.

Risk of pathogen transmission: Advanced screening reduces but does not eliminate risk.

Patient adherence challenges: Particularly in chronic conditions requiring frequent infusions.

Addressing these challenges is critical for sustainable growth and market expansion.

Future Outlook (2026-2035)

The Plasma Protein Therapeutics Market is poised for steady expansion driven by:

Technological advancements in plasma fractionation and recombinant therapeutics.

Increasing adoption of home infusion therapies and outpatient services.

Expansion into emerging markets with growing awareness and healthcare access.

Development of novel plasma proteins targeting rare and chronic conditions.

By 2035, the market is expected to reach USD 58.30 billion, reflecting the sustained importance of plasma therapeutics in modern healthcare.

Discover More Reports

Dental Laboratories Market - https://bit.ly/3XDJUiI.

Energy Recovery Ventilator Market - https://bit.ly/4o1VcYY.

Emergency Escape Breathing Device Market - https://bit.ly/3X6PmdR.

Nootropics Market - https://bit.ly/4oNrHvd.

Media Contact

Company Name: Claight Corporation
Contact Person: Roshan Kumar, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com

About Us

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.

Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Plasma Protein Therapeutics Market to Reach USD 58.30 Billion by 2035 here

News-ID: 4330967 • Views:

More Releases from Expert Market Research

AI in Mental Health Market to Reach USD 8.38B by 2035
AI in Mental Health Market to Reach USD 8.38B by 2035
How Is Artificial Intelligence Transforming Mental Healthcare? The Artificial Intelligence in Mental Health Market is rapidly emerging as a transformative force in global healthcare, addressing long-standing challenges such as access, affordability, stigma, and workforce shortages. With more than 970 million people worldwide affected by mental health conditions, the need for scalable, personalized, and data-driven mental health solutions has never been more urgent. The global artificial intelligence in mental health market was valued
Brazil Clinical Microbiology Market USD 390.12M | 5.8% CAGR
Brazil Clinical Microbiology Market USD 390.12M | 5.8% CAGR
Why is the Brazil Clinical Microbiology Market gaining strategic importance within Latin America's healthcare ecosystem? Brazil has one of the largest and most complex healthcare systems in the region, with a growing focus on early disease detection, antimicrobial resistance monitoring, and laboratory automation. Clinical microbiology plays a critical role in identifying infectious diseases, guiding targeted therapies, and supporting public health surveillance. The Brazil clinical microbiology market was valued at USD 390.12 Million
Battery Recycling Market Size, Trends and Forecast 2026-2035
Battery Recycling Market Size, Trends and Forecast 2026-2035
The battery recycling market is gaining steady traction as industries and governments focus more on resource efficiency, environmental compliance, and supply chain security for critical metals. With the rising use of lithium-ion, lead-acid, and nickel-based batteries across electric vehicles, consumer electronics, industrial equipment, and energy storage systems, recycling has moved from being a regulatory requirement to a strategic necessity. Battery recycling helps recover valuable materials like lithium, cobalt, nickel, and
Biometrics Technology Market Size, Trends & Forecast 2026-2035
Biometrics Technology Market Size, Trends & Forecast 2026-2035
The biometrics technology market is witnessing robust growth and is expected to continue expanding at a significant pace. Valued at approximately USD 27.78 billion in 2025, the market is projected to grow at a compound annual growth rate (CAGR) of 10.20% between 2026 and 2035. By 2035, the market is expected to reach USD 73.38 billion. This growth is driven by the increasing need for advanced security solutions, innovations in

All 5 Releases


More Releases for Plasma

Blood Plasma Freezers Market Safeguarding Plasma Derivatives: Blood Plasma Freez …
Global Blood Plasma Freezers Market Worth $772.0 Mn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Blood Plasma Freezers Market- (By Type (Manual Defrost, Automatic Defrost), By Application (Hospital, Laboratory), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Blood Plasma Freezers Market
Contract Plasma Coating Service Market Analysis, Size, Share, Trends, Growth And …
The Global Contract Plasma Coating Service Market report is added by WMR to its database to offer a complete assessment of the factors influencing an overall market growth trend. The research covers significant data and proves to be a handy resource document for industry experts. The research is a perfect balance bridging both qualitative and quantitative information of this market. Quantitative statistics with qualitative reasoning related to market size, share,
Cold Plasma Market Analysis By Top Keyplayers - Plasma Air, Atmospheric plasma t …
The "Cold Plasma Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Cold Plasma Market, 2024-2031 Verified Market Research's most recent report, "Cold Plasma Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination
Contract Plasma Coating Service Market Revenue Sizing Outlook Appears Bright| He …
The Latest research study released by HTF MI "Global Contract Plasma Coating Service Market with 120+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know-how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint, and status. Understanding the segments helps in identifying the importance of different factors that aid market growth. Some of the Major Companies covered in this Research
Contract Plasma Coating Service Market Players Leveraging on Growth Opportunitie …
The Most recent study offered by "Stratagem Market Insights" focuses on Contract Plasma Coating Service Market size, share, growth rate, and market trends, as well as the parameters and factors influencing it in both the long term and short term. The report investigates the market trends in order to assess its current and future potential. Our Market analysis also provides market participants and new entrants with a comprehensive view of
Cold Plasma Market Size, Share - Global Industry Forecast 2032 | Relyon Plasma G …
The market research report offers an in-depth analysis of the Cold Plasma market, helping players to prepare for the increasing hurdles ahead and ensure continued business expansion. With impeccable analysis, exhaustive research, and accurate forecasting, we provide a clear and authoritative study of the global Cold Plasma market, backed by data and figures that have undergone a rigorous verification process. This research is an exhaustive, comprehensive and carefully curated source